Research Group Adema Salud IUNICS, 07003 Palma, Spain.
Faculty of Dentistry, University School ADEMA, 07009 Palma, Spain.
Nutrients. 2023 Apr 27;15(9):2105. doi: 10.3390/nu15092105.
Atherogenic dyslipidaemia (AD) and lipid triad (LT) are characterised by high triglyceride levels together with low HDL and normal or high LDL cholesterol and are favoured by a persistent state of insulin resistance (IR), which increases the release of free fatty acids from abdominal adipose tissue. This alteration in the lipid profile favours the accelerated development of atherosclerosis, which is the most important cause of morbidity and mortality in all countries in the developed and developing world. One of the elements that plays a major role in the genesis of AD is IR. The aim of this study was to determine the relationship between variables that assess atherogenic risk (AD and LT) and scales that assess the risk of presenting insulin resistance.
A descriptive cross-sectional study of 418,343 workers was conducted to evaluate atherogenic dyslipidaemia and lipid triad; a relationship with three insulin resistance risk scales (Triglycerides/HDL, TyG index, METS-IR) was established. The usefulness of IR risk scales for predicting AD and LT was calculated by applying ROC curves, obtaining the area under the curve (AUC) and cut-off points with their sensitivity, specificity, and Youden index. Multivariate analysis was performed by binary logistic regression.
The prevalence of high-risk values for insulin resistance with all of the scales is much higher in people with AD and LT compared to those without. The ROC curves present us with an AUC with the three insulin resistance risk scales for the two dyslipidaemias studied with figures ranging between 0.856 and 0.991, which implies that the results are good/very good.
A relationship between atherogenic dyslipidaemia and the three insulin resistance risk scales assessed is revealed, with higher IR mean values and prevalence in people with atherogenic dyslipidaemia and lipid triad. The three scales make it possible to adequately classify the presence of AD and LT. The highest AUC is presented by the triglycerides/HDL scale, with a result close to 1. METS-IR is the most recommended formula to estimate insulin resistance.
致动脉粥样硬化性血脂异常(AD)和脂质三联征(LT)的特征是甘油三酯水平升高,同时高密度脂蛋白胆固醇降低,而 LDL 胆固醇正常或升高,并且与持续的胰岛素抵抗(IR)有关,这会增加腹部脂肪组织中游离脂肪酸的释放。这种脂质谱的改变有利于动脉粥样硬化的加速发展,这是所有发达国家和发展中国家发病率和死亡率的最重要原因。在 AD 的发病机制中起主要作用的因素之一是 IR。本研究的目的是确定评估动脉粥样硬化风险的变量(AD 和 LT)与评估胰岛素抵抗风险的量表之间的关系。
对 418343 名工人进行了描述性横断面研究,以评估致动脉粥样硬化性血脂异常和脂质三联征;建立了与三种胰岛素抵抗风险量表(甘油三酯/高密度脂蛋白、TyG 指数、METS-IR)的关系。通过应用 ROC 曲线,获得曲线下面积(AUC)和截断值及其灵敏度、特异性和 Youden 指数,计算了 IR 风险量表预测 AD 和 LT 的有用性。通过二元逻辑回归进行多变量分析。
与所有量表相比,具有 AD 和 LT 的个体中,所有量表的胰岛素抵抗高风险值的患病率要高得多。ROC 曲线为我们提供了三种胰岛素抵抗风险量表对两种血脂异常的 AUC,数值在 0.856 到 0.991 之间,这意味着结果是好的/非常好的。
揭示了致动脉粥样硬化性血脂异常与三种评估的胰岛素抵抗风险量表之间的关系,在致动脉粥样硬化性血脂异常和脂质三联征患者中,IR 的平均值和患病率更高。三种量表都可以很好地对 AD 和 LT 的存在进行分类。AUC 最高的是甘油三酯/高密度脂蛋白比值,结果接近 1。METS-IR 是估计胰岛素抵抗最推荐的公式。